Sappayani, Shirlina J.
HRN: 23-31-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2023
CEFUROXIME 750MG (VIAL)
07/16/2023
07/23/2023
IV
1.5 Gm
Q8
S/P Primary LTCS With PPIUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose